Financial Review

…Nasdaq record high. Trade wars on the horizon. G-6-plus-1 later in the week. M&A around the world. Microsoft gets Github. Buybacks, M&A, & dividends push markets. Apple WWDC. Facebook, again. Financial Review by Sinclair Noe for 06-04-2018 DOW + 178 = 24,813 SPX + 12 = 2746 NAS + 52 = 7606 RUT + 5 = 1653 10 Y + .04 = 2.94% OIL – 1.19 = 64.62 GOLD – 1.60 = 1292.50   Tech stocks led today’s rally and helped push the Nasdaq to a record high close. The Nasdaq Biotechnology Index underperformed the broader market with a 0.7 percent decline Nektar Therapeutics dropped 41% and weighed on the index after mixed results from its experimental cancer drug with Bristol-Myers Squibb’s Opdivo disappointed investors. Bristol-Myers Squibb ended 3.2 percent lower. Merck, however, gained about 2.4 percent after latest data showed its cancer drug Keytruda improved survival as a stand-alone treatment for a type of lung cancer. Falling oil prices weighed on the energy sector.   Weekend trade talks between the U.S. and China ended